NLS Pharmaceutics (NLSP) News Today $1.95 -0.43 (-18.07%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period NLS Pharmaceutics and Kadimastem Advance Diabetes Treatment with FDA SubmissionDecember 20 at 10:51 AM | markets.businessinsider.comNLS Pharmaceutics Plans Capital Increase at Extraordinary Shareholders’ MeetingDecember 17, 2024 | markets.businessinsider.comNLS Pharmaceutics Ltd. (NASDAQ:NLSP) Short Interest UpdateDecember 13, 2024 | americanbankingnews.comNLS Pharmaceutics Offers New Investment OpportunitiesDecember 6, 2024 | markets.businessinsider.comNLS Pharmaceutics Ltd. Announces Pricing of Private Placement of up to $1 Million at a 15% Premium to the MarketDecember 4, 2024 | prnewswire.comNLS Pharmaceutics AG Announces Share Capital ExpansionNovember 16, 2024 | markets.businessinsider.comKadimastem Ltd. Faces Financial UncertaintyNovember 13, 2024 | markets.businessinsider.comNLS Pharmaceutics Announces Strategic Capital RestructuringNovember 7, 2024 | markets.businessinsider.comNLS Pharmaceutics and Kadimastem Announce Strategic MergerNovember 6, 2024 | markets.businessinsider.comNLS Pharmaceutics (NASDAQ:NLSP) Stock, Short Interest ReportNovember 4, 2024 | benzinga.comNLS Pharmaceutics, Kadimastem enter definitive merger agreementNovember 4, 2024 | markets.businessinsider.comNLS Pharmaceutics Merges with Kadimastem for Strategic GrowthNovember 4, 2024 | markets.businessinsider.comWhat's Going On With NLS Pharmaceutics Shares Monday?November 4, 2024 | msn.comNLS Pharmaceutics stock jumps 50% on merger agreement with cell therapy firm KadimastemNovember 4, 2024 | msn.comNLS Pharmaceutics Achieves Nasdaq Compliance MilestoneOctober 29, 2024 | markets.businessinsider.comNLS Pharmaceutics regains full compliance with Nasdaq listing rulesOctober 29, 2024 | markets.businessinsider.comNLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing RequirementsOctober 28, 2024 | finance.yahoo.comNLS Pharmaceutics secures patent in Japan for Mazindol EROctober 22, 2024 | markets.businessinsider.comNLS Pharmaceutics Sees Reduced Losses Amid Financial ChallengesOctober 20, 2024 | finance.yahoo.comWhy Is NLS Pharmaceutics (NLSP) Stock Up 48% Today?July 29, 2024 | investorplace.comNLS Pharmaceutics to Absorb Kadimastem as Subsidiary After Agreeing to MergerJuly 29, 2024 | marketwatch.comKadimastem To Become Subsidiary Of NLS; Kadimastem Shareholders To Hold 85% Of Merged Company SharesJuly 29, 2024 | markets.businessinsider.comNLSP NLS Pharmaceutics AGJuly 26, 2024 | seekingalpha.comWhy Is NLS Pharmaceutics (NLSP) Stock Down 23% Today?June 20, 2024 | investorplace.comWhy Is NLS Pharmaceutics (NLSP) Stock Up 163% Today?June 18, 2024 | investorplace.comNLS Pharmaceutics Reports Positive Results from Study KO-874 on Mazindol's Neuroprotective Effects in Narcoleptic-like Rat ModelMay 28, 2024 | stockhouse.comNLS Pharmaceutics AG: NLS Pharmaceutics Announces Receipt of Additional Staff Delisting Determination from NasdaqMay 24, 2024 | finanznachrichten.deNLS Pharmaceutics Announces Receipt of Additional Staff Delisting Determination from NasdaqMay 24, 2024 | finance.yahoo.comNLS Pharmaceutics AG: NLS Pharmaceutics Announces Closing of $1.75 Million Registered Direct OfferingMarch 22, 2024 | finanznachrichten.deNLS Pharmaceutics AG: NLS Pharmaceutics Secures Exclusive Global License for Next-Generation Non-Sulfonamide Dual Orexin Agonist PlatformMarch 20, 2024 | finanznachrichten.deNLS Pharmaceutics AG: NLS Pharmaceutics Announces $1.75 Million Registered Direct OfferingMarch 20, 2024 | finanznachrichten.deNLS Pharmaceutics AG: NLS Pharmaceutics to Participate in the BIO-EUROPE Springtime Partnering EventMarch 14, 2024 | finanznachrichten.deNLS Pharmaceutics AG: Nasdaq Accepts NLS Pharmaceutics' Plan to Regain Listing ComplianceMarch 11, 2024 | finanznachrichten.deNasdaq Accepts NLS Pharmaceutics’ Plan to Regain Listing ComplianceMarch 11, 2024 | finance.yahoo.comNLS Pharmaceutics AG: NLS Pharmaceutics Submits Plan to Regain Listing Compliance With NasdaqFebruary 23, 2024 | finanznachrichten.deNLSP NLS Pharmaceutics Ltd.February 14, 2024 | seekingalpha.comNotice of Deficiency with Nasdaq Continued Listing RequirementsJanuary 20, 2024 | finance.yahoo.comNLS Pharmaceutics AG: Notice of Deficiency with Nasdaq Continued Listing RequirementsJanuary 12, 2024 | finanznachrichten.deNLS Pharmaceutics Stock (NASDAQ:NLSP) Insider TradesDecember 23, 2023 | benzinga.comNLS Pharmaceutics Ltd Ordinary SharesDecember 21, 2023 | morningstar.comNLS Pharmaceutics Stock (NASDAQ:NLSP) Dividends: History, Yield and DatesDecember 5, 2023 | benzinga.comNLS Pharmaceutics Announces Exclusive Option Agreement to Develop and Commercialize Next Generation Dual Orexin Agonist Platform of Aexon Labs, Inc.December 1, 2023 | finance.yahoo.comNLS Pharmaceutics AG: NLS Pharmaceutics to Participate in the Oppenheimer Sleep Disorders Summit: Deep Dive into Narcolepsy and Idiopathic HypersomniaNovember 27, 2023 | finanznachrichten.deNLS Pharmaceutics Ltd Ordinary Shares NLSPNovember 21, 2023 | morningstar.comWhy NLS Pharmaceutics (NLSP) Stock Is Down 40% TodayNovember 16, 2023 | msn.comNLS Pharmaceutics Announces Selection of Strategic Partner and Securing a Bridge LoanNovember 16, 2023 | finance.yahoo.comNLS Pharmaceuticals to Reschedule Company Update on Strategic DiscussionsOctober 19, 2023 | finance.yahoo.comNLS Pharmaceutics AG: NLS Pharmaceutics Announces Company Update on Strategic PartnershipsOctober 12, 2023 | finanznachrichten.deNLS Pharmaceutics Announces Company Update on Strategic PartnershipsOctober 12, 2023 | finance.yahoo.comNLS Pharmaceutics (NLSP) Price Target Increased by 24.47% to 9.95October 5, 2023 | msn.com Get NLS Pharmaceutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NLSP and its competitors with MarketBeat's FREE daily newsletter. Email Address 70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (Ad)Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets. >> You can grab your FREE, laminated copies right here << NLSP Media Mentions By Week NLSP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NLSP News Sentiment▼0.210.60▲Average Medical News Sentiment NLSP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NLSP Articles This Week▼20▲NLSP Articles Average Week Get NLS Pharmaceutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NLSP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NextCure News Forte Biosciences News KALA BIO News Daré Bioscience News Longeveron News Lipocine News Pluri News LAVA Therapeutics News Natural Alternatives International News Enlivex Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NLSP) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NLS Pharmaceutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share NLS Pharmaceutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
